Catalysts for Chiesi USA Inc
23 tracked
Apr 1, 2026
recall
Chiesi USA, Inc. recall (Cls II)
Chiesi USA Inc
→
Feb 25, 2026
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Jun 16, 2022
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Feb 1, 2022
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
May 27, 2021
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Dec 20, 2019
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Jun 4, 2018
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Aug 2, 2017
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Jan 3, 2017
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Jan 3, 2017
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Jul 11, 2016
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
May 23, 2016
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Mar 8, 2016
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Apr 24, 2015
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Apr 23, 2015
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Nov 11, 2014
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Aug 8, 2014
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Apr 23, 2014
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Feb 18, 2014
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Dec 17, 2013
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Aug 13, 2013
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Apr 10, 2013
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→
Dec 21, 2012
approval
JUXTAPID (LOMITAPIDE MESYLATE) — FDA approval
Chiesi USA Inc
→